Transdermal Excipients

Excipients for use with transdermal systems are often used for rheology modification, stability, API compatibility, temperature resilience, viscoelasticity microbe resistance and low irritancy properties.

Your search returned 1 Transdermal Excipient Search across 1 supplier.

Sort By

Select All

Select up to 5 products from below to compare or request more information.

Compare

Product / Company	Functionality	Application	Price
Captex 200P ABITEC	Solubilizer	Inquire	Get quote White Paper SDI Phase	Compare or Get quote for selected.

Select All

Select up to 5 products from above to compare or request more information.

Compare

Tags:

Please Login or Register to Create Tags

Feedback

Articles

Trends in Pharmaceutical Excipients: An Update
Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective
Development of Freeze-dried Formulations Using Thermal Analysis and Microscopy
Quality-by-Design for Freeze-Thaw of Biologics: Concepts and Application to Bottles of Drug Substance
Application Challenges and Examples of New Excipients in Advanced Drug Delivery Systems
Amorphous Solid Dispersions as Enabling Formulations for Discovery and Early Development
Ion Chromatography in USP-NF
Parenteral Products: Pharmacopeial Control of Containers, Storage and Distribution
Evaluation of In-Situ Fiber Optics Dissolution Method for Compound A Extended Release Tablets
Compendial Standards and Excipient Performance in the QbD Era: USP Excipient Performance Chapter <1059>
Davisco Foods International, Inc. and Meggle Group announce a Joint Venture for the Production of Pharmaceutical Lactose
Hot-stage Optical Microscopy as an Analytical Tool to Understand Solid-state Changes in Pharmaceutical Materials
Advances in Lipid-based Formulations: Overcoming the Challenge of Low Bioavailability for Poorly Water Soluble Drug Compounds
Mechanism of Stabilization of Proteins by Poly-hydroxy Co-solvents: Concepts and Implications in Formulation Development
Miniaturized Equipment for Early Formulation Development
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
In Vitro High-throughput Drug Precipitation Methods for Oral Formulations
An Interview with DSM
Why is GMP Training a Necessity at Excipient Sites?
Stability Testing – Doing Everything or Doing the Right Thing?
Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
Using Process Analytical Technologies for Real Time Monitoring and Quality Assurance in Chemical Development
Functionality and Performance of Excipients in a Quality-by-Design World Part X: Continuous Processing of Pharmaceutical Finished Products
Functionality and Performance of Excipients in a Quality-by-Design World, Part IX: New Excipients
New VitalDose® Blog Debuts
Functionality and Performance of Excipients in Quality-by-Design World, Part VIII: Excipient Specifications
Functionality and Performance of Excipients in Quality-by-Design World, Part VII: Quality Risk Management
Functionality and Performance of Excipients in Quality-by-Design World Part VI: Excipient Composition
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co. Ltd. and Extensive Investments to it's Zydis® to Technology Capabilities in Swindon, UK
Functionality and Performance of Excipients in Quality-by-Design World Part V: Changes in the Sourcing and Supply of Pharmaceutical Excipients
An Interview with Meggle
An Interview with DSM
Use of Enzymes in the Dissolution Testing of Gelatin Capsules
The Impact of USP’s New Elemental Impurities Standards on Manufacturers, Suppliers and Contract Laboratories
BASF Extends Offer Period for Pronova BioPharma
BASF Increases Cash Offer for Pronova BioPharma
The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities
BASF Starts Up tert. Butylamine plant in Nanjing, China
CPhI opens Awards to Global Pharma Industry, Celebrating Tomorrow’s Innovations Today
The Creation of an Excipient Properties Database to Support Quality by Design (QbD) Formulation Development
Controlled Release Pulmonary Therapies: Promises and Concerns
CPhI Report Indicates a Need for Greater Third Party Certification to Ensure GMP Vigilance
Aesica Appoints Ian Muir to Newly Created Commercial Managing Director Position
CPhI Announces USA Market Report at InformEx
Pharmaceutical Excipients Identification With Handheld Raman
An Interview With Jasmine Musakhanian, M.Sc. Marketing & Scientific Director of Pharmaceutical Division Gattefossé USA
CELPHERE MCC Spherical Seed Core
CEOLUS KG Grade Microcrystalline Cellulose
CEOLUS PH Grade Microcrystalline Cellulose
CEOLUS UF Grade Microcrystalline Cellulose
Soluplus
Kollicoat IR Color Coating System
Actimask® Acetaminophen 92M
Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017
Gattefossé North America Announces Recipient of 2017 Award for Excellence
An Interview With Shaukat Ali, PhD
ABITEC, UNIVAR Canada Announce Specialty Lipid Distribution Agreement
Tracking Host Cell Proteins During Biopharmaceutical Manufacturing: Advanced Methodologies to Ensure High Product Quality
Particle Engineering For Improved Bioavailability In Oral Solid Dose Medications
World’s First Triple Compound: CombiLac® from Meggle
Lipids in Transdermal and Topical Drug Delivery
Trends and Innovations in Oral Drug Delivery Round Table
An Interview With... Dr. Egmont G. Pfeifer and Dr. Albrecht Krämer of MEGGLE Group
Taste Masking Techniques in the Pharmaceutical Industry
Roundtable: Excipient Trends/Challenges
Forensics in QbD: Addressing Foreign Particulate Matter Investigations
Hydroxypropyl Cellulose for Orally Disintegrating Film Drug Application
Micromeritics to Participate in University of Maryland Tableting Course
Natoli Debuts New Website
First GMP-Compliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use
Catalent Announces Two Senior Executive Appointments to Support Global Development and Clinical Services Business Growth
Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand
Almac Makes Further Significant co-investment to Meet Japanese Client Demand for Humidity Controlled Blister Packaging
BASF and Colorcon Cooperate on Kollicoat^® IR for Ready-to-Use Pharmaceutical Coating Solutions
EMD Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products
Pharmaceutical Excipients Identification With Handheld Raman
BASF to Build New World-scale Plant for Specialty Amines in Ludwigshafen
Quotient Clinical Extends its Translational Pharmaceutics™ Platform into Cancer Drug Development
Croda Celebrates EXCiPACTTM “Double”
CPhI Pharma Awards Winners Showcase the Innovations Driving Pharma
Thermo Fisher Scientific Receives Clearance from the European Commission for its Acquisition of Life Technologies
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Catalent Pharma Solutions and Adamas Pharmaceuticals Enter Into Phase 3 Clinical Trials Manufacturing Agreement for Potential New Treatment for Levodopa Induced Dyskinesia
BASF Received EXCiPACTTM Certification as Pharmaceutical Excipient Supplier
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Merck KGaA: Allergopharma Plans to Invest € 40 Million in Production Facility
Expert Presentations at Australia Workshop on Powder Characterisation and Inhaler Testing
CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals with Expanded Content and First Annual Report
Vetter Launches New Clinical Syringe Packages
The New Dawn of Pharmaceutical Manufacturing: Innovative Solutions for Unprecedented Challenges
Colorcon, Inc. Launches First Certified Organic Coating System for Dietary Supplement Tablets
Tergus Grows Manufacturing Capabilities Tergus Grows Manufacturing Capabilities
Investigation of Excipient Compatibility and Associated Degradations for the Formulation Development of a Small Molecule Pharmaceutical Compound
Rapid Detection of Counterfeit Drugs of Ethambutol Hydrochloride and Cefuroxime Axetil using Handheld Raman, Near Infrared and Portable FTIR Technologies
Are HPLC-UV Methods Fit for Purpose as True Arbiters of Quality for APIs?
A Recent Advancement in Orally Disintegrating Formulations
BASF pharmaceutical solutions presented at CPhI Worldwide in Frankfurt, Germany
API, Excipient, and Dosage Form Characterization Solutions for the Identity and Control of Critical Quality Attributes (CQA)
Future of Transdermal Drug Delivery Systems (TDDS)
Solid State Considerations for Early Development
Utilizing a Novel Disperser Technology to Accelerate Sample Extraction of Pharmaceutical Solid Dosage Forms
Crodasol HS HP
Parteck LUB STA 50 Vegetable Grade Stearic Acid 50
“Joshi Capsules” US patent numbers – 8728521 and 9884024
The KEY TO Pharma’s Next Generation Success
The Evaluation of Dual Laser Handheld Raman Spectroscopy for Identifying Novel Psychoactive Substances
Automated and Rapid Methods to Assess Quality & Stability of Biologics: Recent Developments and Practical Ways to Implement Them in Formulation Development
Drug Delivery Roundtable
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs, and Excipients
Theory of Sampling (TOS) for Development of Spectroscopic Calibration Models
An Interview With Andreas Gryczke, Global Technical Marketing Solubilization BASF Pharma Solutions
Recent Innovations in Pharmaceutical Hot Melt Extrusion

Transdermal Excipients

Captex 200P

Articles

Transdermal Excipients

Process

Functionality

Companies

Featured Products

Actimask® Acetaminophen 92M

Crodasol HS HP

Parteck LUB STA 50 Vegetable Grade Stearic Acid 50

Subscriptions

Connect with Us

Related Articles

Development of Freeze-dried Formulations Using ...

Size Exclusion Chromatography of Protein ...

FDA’s Regulatory Science Program for Generic PLA/ ...